Report overview
The HBV PCR detection Kit is intended for research and diagnostic applications. The HBV PCR detection Kit is an in vitro Nucleic Acid Test (NAT) based pathogen detection product. The HBV PCR detection Kit is designed to detect Hepatitis B Virus (HBV) nucleic acids in human blood plasma.
This report contains market size and forecasts of Hepatitis B Virus Nucleic Acid Assay Kit in global, including the following market information:
Global Hepatitis B Virus Nucleic Acid Assay Kit Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Hepatitis B Virus Nucleic Acid Assay Kit Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Hepatitis B Virus Nucleic Acid Assay Kit companies in 2022 (%)
The global Hepatitis B Virus Nucleic Acid Assay Kit market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Ultra-sensitive Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Virus Nucleic Acid Assay Kit include Abbott, altona Diagnostics, GeneProof, Roche Diagnostics, Biogerm Medical, Liferiver, Mole Bioscience, Bioperfectus and Rendu Biotechnology, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Virus Nucleic Acid Assay Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Virus Nucleic Acid Assay Kit Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Assay Kit Market Segment Percentages, by Type, 2022 (%)
Ultra-sensitive
High Sensitivity
General Sensitivity
Global Hepatitis B Virus Nucleic Acid Assay Kit Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Assay Kit Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Hepatitis B Virus Nucleic Acid Assay Kit Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Hepatitis B Virus Nucleic Acid Assay Kit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Virus Nucleic Acid Assay Kit revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis B Virus Nucleic Acid Assay Kit revenues share in global market, 2022 (%)
Key companies Hepatitis B Virus Nucleic Acid Assay Kit sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatitis B Virus Nucleic Acid Assay Kit sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
altona Diagnostics
GeneProof
Roche Diagnostics
Biogerm Medical
Liferiver
Mole Bioscience
Bioperfectus
Rendu Biotechnology
Applied Biological
Sansure Biotech
Coyote Bioscience
Daan Gene
BGI Group
Orient Gene
